Send me a link:

*Text messaging rates may apply.

 Dow Up 0.12% Nasdaq Down 0.08%

Seattle Genetics Inc. (SGEN)

-NasdaqGS
34.41 Down 0.48(1.38%) 3:38PM EDT - Nasdaq Real Time Price
Prev Close:34.89
Open:35.00
Bid:34.40 x 200
Ask:34.44 x 200
1y Target Est:45.15
Beta:1.29
Next Earnings Date:31-Jul-14SGEN Earnings announcement
Day's Range:33.75 - 35.20
52wk Range:32.35 - 55.99
Volume:496,877
Avg Vol (3m):1,085,680
Market Cap:4.24B
P/E (ttm):N/A
EPS (ttm):-0.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SGEN

Comparison

Symbol% ChgMkt Cap
SGENDown 1.38%4.24B
IMGNDown 0.85%904.47M
PFEDown 0.41%191.78B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.91
Quarterly EPS Est (Jun-14) :-0.22
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-9.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback